Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AZN

Astrazeneca plc

169.64

Jul 27 • 3:59 PM ET +0.38 (0.22%)

169.78

Aftermarket • 7:41 PM ET +0.14 (0.09%)

Healthcare Drug Manufacturers - General United Kingdom Mega NYSE

Jul 27, 8:30 AMAstraZeneca Q2 2026 EPS $2.63 beats estimates as it lifts tozorakimab peak sales forecast to above $5B from $3B

Peers: LLY MRK PFE ABBV JNJ NVS GSK BMY SNY AMGN

| Held by: PVAL AVDE DIHP DFIC PPH PBPH FVD DFAX JDVL BDYN

Scroll to Statements

Index	-
Market Cap	263.09B
Enterprise Value	290.44B
Income	10.45B
Sales	61.37B
Book/sh	32.43
Cash/sh	3.20
Dividend Est.	3.32 (1.96%)
Dividend TTM	3.20 (1.89%)
Dividend Ex-Date	Feb 20, 2026
Dividend Gr. 3/5Y	1.78% 3.25%
Payout	47.19%
Employees	96100
IPO	Oct 17, 2003

P/E	25.35
Forward P/E	14.69
PEG	1.24
P/S	4.29
P/B	5.23
P/C	52.96
P/FCF	24.20
EV/EBITDA	14.46
EV/Sales	4.73
Quick Ratio	0.67
Current Ratio	0.89
Debt/Eq	0.64
LT Debt/Eq	0.52
Option/Short	Yes / Yes

EPS (ttm)	6.69
EPS next Y	11.55
EPS next Q	2.65
EPS this Y	12.06%
EPS next Y	12.48%
EPS next 5Y	11.83%
EPS past 3/5Y	45.90% 22.05%
Sales past 3/5Y	9.82% 16.31%
EPS Y/Y TTM	33.66%
Sales Y/Y TTM	8.61%
EPS Q/Q	2.26%
Sales Q/Q	6.41%
Earnings	Jul 27 BMO
EPS/Sales Surpr.	5.98% -0.32%

Insider Own	-
Insider Trans	-
Inst Own	62.47%
Inst Trans	-8.59%
ROA	9.15%
ROE	21.99%
ROIC	13.69%
Gross Margin	73.93%
Oper. Margin	22.38%
Profit Margin	17.02%
SMA20	-3.98%
SMA50	-5.82%
SMA200	-7.73%
Trades

Shs Outstand	1.55B
Shs Float	1.50B
Short Float	0.17%
Short Ratio	1.13
Short Interest	2.53M
52W High	212.71 -20.25%
52W Low	141.77 19.66%
Volatility	2.14% 2.25%
ATR (14)	4.72
RSI (14)	42.55
Beta	0.32
Rel Volume	1.72
Avg Volume	2.24M
Volume	3,861,409

Perf Week	3.11%
Perf Month	-8.64%
Perf Quarter	-10.60%
Perf Half Y	-4.43%
Perf YTD	-3.34%
Perf Year	15.46%
Perf 3Y	20.78%
Perf 5Y	48.35%
Perf 10Y	176.24%
Recom	1.68
Target Price	214.74
Prev Close	169.26
Price	169.64
Change	0.22%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-13-26	Downgrade	HSBC Securities	Buy → Hold

Jul-27-26 03:16PM	AstraZeneca's $2.63 Earnings Beat Supports $80 Billion Revenue Target (GuruFocus.com)
03:00PM	AstraZeneca PLC (AZN) Q2 2026 Earnings Call Highlights: Strong Oncology and Rare Disease Growth ... (GuruFocus.com)
01:04PM	US Futures Rise as Megacap Earnings and Fed Decision Headline Quarter's Busiest Week (GuruFocus.com)
12:25PM	AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst A Look At Some Key Highlights (Stocktwits)
11:26AM	AstraZeneca quarterly net profit rises 2% on strong cancer drug sales (Euronews)
07:56AM	Loading…
07:56AM	AstraZeneca Q2 2026 earnings beat on cancer drug sales (Quartz)
07:52AM	Earnings live: AstraZeneca stock rises to kick off a busy earnings week (Yahoo Finance)
07:29AM	AstraZeneca profit rises on strong cancer drug sales (AFP)
02:43AM	AstraZeneca shares climbs as full-year outlook reiterated despite recent trial failure - UPDATE (Proactive)
02:43AM	AstraZeneca earnings beat forecasts despite slight revenue miss (Proactive)
02:16AM	FTSE 100 Live: Strong start expected to busy week as AstraZeneca, Vodafone report results (Proactive)
02:16AM	FTSE 100 Live: Stocks start higher as oil price tumbles, Vodafone and AstraZeneca impress (Proactive)
02:16AM	FTSE 100 Live: Stocks advance as oil price retreats, retail downturn eases (Proactive)
02:15AM	Astrazeneca: Q2 Earnings Snapshot (Associated Press)
Jul-24-26 09:15AM	AstraZeneca PLC (LSE:AZN) Q2 2026: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
05:00AM	Loading…
05:00AM	Novo escalates legal fight with Lilly; J&J reinforces dominance in multiple myeloma (BioPharma Dive)
Jul-22-26 10:50AM	Jefferies says September lung data can offset AstraZeneca trial failure (Proactive)
10:10AM	Trump Takes Another Swing at Drug Industry in Made-in-USA Push (Bloomberg)
Jul-17-26 06:31AM	MSD wins FDA approval for cholesterol pill to help plug Keytruda void (Pharmaceutical Technology)
Jul-15-26 08:49AM	After Crinetics' $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story? (FinanceWire)
06:00AM	Eli Lilly-Backed Novel Cancer Therapy Firm Raises $315 Million (Bloomberg)
05:18AM	J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals (BioPharma Dive)
Jul-14-26 11:14AM	AstraZeneca pays up to $1.5bn to license Dizal Pharmas lung cancer drug (Pharmaceutical Technology)
03:16AM	AstraZeneca to pay up to $1.5bn for global rights to lung cancer pill (Proactive)
Jul-13-26 08:32AM	AstraZeneca Shares Slip After HSBC Cuts Rating Following Wainua Setback (AZN) (Investors Hub)
08:15AM	Biogen Stock Is Upgraded to Buy Ahead of Key Alzheimer's Drug Study Details (Barrons.com)
08:06AM	HSBC downgrades AstraZeneca after key trial failure (Proactive)
07:31AM	UBS stays positive on AstraZeneca ahead of second-quarter results (Proactive)
07:09AM	AstraZeneca stock dips as HSBC downgrades stock on tough path ahead (Investing.com)
02:19AM	FTSE 100 Live: Stocks search for direction as energy markets react to US-Iran strikes (Proactive)
02:19AM	Loading…
02:19AM	FTSE 100 Live: Stocks flat as Trump says US to be 'guardian of Hormuz strait' (Proactive)
Jul-10-26 12:01AM	AstraZeneca Plunges After New Heart Disease Drug Fails Trial (The Daily Upside)
Jul-09-26 04:41PM	Stocks shrug off tensions to rise on renewed tech interest (AFP) -5.70%
03:39PM	Trending: Salesforce stock dips on Keybanc downgrade, AstraZeneca drug trial falls short (Yahoo Finance Video)
02:02PM	AstraZeneca Slides 9.9% After Heart Drug Trial Misses Late-Stage Goal (GuruFocus.com)
11:28AM	AstraZeneca and Ionis stocks drop significantly on Wainua ATTR-CM trial failure (Clinical Trials Arena)
11:27AM	AstraZeneca Gets a Rare Clinical Black Eye (Moby)
09:15AM	AstraZeneca's Wainua failure hurts credibility more than valuation, Jefferies warns (Proactive)
08:40AM	AstraZeneca Falls After Wainua Heart Disease Trial Fails (GuruFocus.com)
08:12AM	Nasdaq set to gain as chips in favor again, as oil rebounds (Proactive)
07:38AM	AstraZeneca Stock and Partner Ionis Sink After Trial Failure. Alnylam Soars. (Barrons.com)
07:14AM	AstraZeneca stock drops 9% after Wainua heart drug trial fails (Quartz)
07:11AM	IONS Stock Heads Toward Biggest Single-Day Slump In Over 5 Years Retail Calls It Opportunity Of A Lifetime (Stocktwits)
06:35AM	Sino and AstraZeneca sign licence agreement for TQC3721 (Pharmaceutical Business Review)
06:00AM	Ionis Pharma dives on drug trial failure, and other early market movers (MarketWatch)
05:53AM	Major drugmaker loses $27 billion in market value after failed trial (MarketWatch)
04:43AM	AstraZeneca Shares Plunge on Rare Trial Failure of Heart Drug (Bloomberg)
03:50AM	AstraZeneca's £19bn blow as Wainua heart drug fails key late-stage trial (Proactive)
02:19AM	FTSE 100 Live: London index hit by AstraZeneca failure, Computacenter and Playtech soar (Proactive)
02:19AM	FTSE 100 Live: Index opens lower after AstraZeneca trial failure, Computacenter surges (Proactive)
Jul-08-26 07:58AM	AstraZeneca, GSK intensify China ties with Sino Biopharm deals (BioPharma Dive)
02:19AM	FTSE 100 Live: Stocks slide as oil spikes, Trump says Iran ceasefire 'over' (Proactive)
Jul-07-26 02:19AM	FTSE 100 Live: Shell and consumer giants make gains, while miners and defence sell off (Proactive)
Jul-06-26 08:55AM	As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models (PR Newswire)
08:45AM	The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel (PR Newswire)
08:03AM	Citi keeps AstraZeneca on 'buy' ahead of second-quarter results (Proactive)
02:17AM	FTSE 100 Live: Stocks slide despite airlines and defence gains, Microsoft slashes jobs (Proactive)
Jul-02-26 02:17AM	FTSE 100 Live: Stocks start to rise across Europe, Currys stumbles (Proactive) +6.14%
02:17AM	FTSE 100 Live: London stocks rocket to 2-month high after US jobs miss (Proactive)
02:17AM	FTSE 100 Live: European stocks and gold rocket after US jobs miss (Proactive)
Jun-30-26 04:10PM	Imviva Biotech Granted FDA IDE Authorization for Cancer Treatment Trial (Exec Edge)
12:57PM	Ipsens $450M blood cancer drug; FDA selects first cohort for pre-check pilot program (BioPharma Dive)
02:15AM	FTSE 100 Live: Blue-chips little changed as Starmer unveils defence plan (Proactive)
Jun-26-26 08:03AM	Jefferies names AstraZeneca a top pick ahead of pivotal heart drug readout (Proactive)
07:42AM	Solvonis Therapeutics, Tertiary Minerals, CelLBxHealth, Coinsilium, Eco Buildings, Frontier IP (Proactive)
Jun-25-26 03:53PM	Candel Therapeutics Designates Mark Sims as CCO (Exec Edge)
Jun-24-26 05:00PM	A $30 Billion Cancer Breakthrough Is Under Threat From Global Conflicts (Bloomberg)
09:00AM	AstraZeneca and YMCA of the USA Announce Landmark Partnership Aimed to Address Gaps in Cancer Care (Business Wire)
Jun-23-26 09:00PM	CelLBxHealth PLC (ANPCF) Full Year 2025 Earnings Call Highlights: Strategic Partnerships and ... (GuruFocus.com)
02:18AM	FTSE 100 Live: London stocks inch higher as Wall Street tech sells off (Proactive)
Jun-22-26 04:51AM	Eco Buildings, Solvonis Therapeutics, CelLBxHealth, NextEnergy Solar Fund, Empire Metals, Coinsilium (Proactive)
Jun-19-26 05:30AM	CelLBxHealth CEO on strategy reset and growth plans (Proactive)
05:13AM	ASCO26: RLTs bring the buzz, but commercial and tolerability qualms remain (Pharmaceutical Technology)
04:49AM	European stocks edge higher, helped by energy and healthcare (Reuters)
Jun-17-26 08:00AM	Big pharma taps UK playbook to pressure Europe on drug prices (Reuters Videos)
Jun-15-26 03:46PM	EHA26: AstraZeneca battles Roche in untreated follicular lymphoma (Clinical Trials Arena)
07:06AM	Factbox-Global drugmakers rush to boost US presence as tariff threat looms (Reuters)
Jun-10-26 05:12AM	AstraZenecas extensive obesity drug push; $125M for ultrasound-aided genetic medicine (BioPharma Dive)
Jun-09-26 10:10AM	GSK Buys Nuvalent for $10.6 Billion in Major Cancer Push (Bloomberg)
Jun-08-26 06:25PM	AstraZeneca's GLP-1 Pill Clears Early Hurdle in Diabetes, Obesity Tests (The Wall Street Journal)
05:32PM	LLY Stock Climbs As Oral GLP-1 Pill Beats Novo Nordisk, AstraZenecas Therapies In Diabetes Trials (Stocktwits)
Jun-06-26 02:53PM	Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy. (MarketWatch)
Jun-05-26 11:00AM	AstraZeneca CFO Dr. Aradhana Sarin Breaks Down Revenue Growth Goals (NYSE)
11:00AM	AstraZeneca Pascal Soriot Delivers Remarks as Firm Celebrates Transfer to NYSE (NYSE)
08:55AM	NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History (PR Newswire)
Jun-03-26 11:00PM	A Spanish biotech banks $87M to make differentiated ADCs (BioPharma Dive)
06:32AM	Leading Bank maintains sell on AstraZeneca at 11,500p as ASCO glow fails to resolve key pipeline questions (Proactive)
Jun-01-26 10:19AM	AIM Stock Soars Over 200% As Pancreatic Cancer Trial Hits Enrollment Milestone Early CEO Sees 'Value-Inflection Period' Ahead (Stocktwits)
10:19AM	AIM Stock Soars 42% As Pancreatic Cancer Trial Hits Key Enrollment Milestone Before Schedule CEO Sees 'Significant Value-Inflection Period' Ahead (Stocktwits)
09:57AM	ASCO 2026: A quiet conference for European pharma, but AstraZeneca and Roche both have work to do (Proactive)
05:06AM	AstraZeneca aims for a new blockbuster run in cardio disease (Pharma Voice)
May-29-26 10:33AM	US bank sees positive risk-reward for AstraZeneca ahead of pivotal heart drug trial (Proactive)
06:17AM	Allogene CEO to step down; Agios drug fails key test (BioPharma Dive)
May-28-26 02:16AM	FTSE 100 Live: London stocks flop as oil and bonds kick back up on Hormuz tensions (Proactive)
May-27-26 11:30PM	SLS Stock Extends Rally Overnight: CEO Says Bullish Leukemia Data Could Drive NCCN Recognition For GPS (Stocktwits)
10:09AM	FDA delays decision on AstraZeneca breast cancer pill (BioPharma Dive)
May-26-26 06:16AM	Astellas eyes more cost cuts; FDA panel to debate Moderna vaccine (BioPharma Dive)
May-25-26 06:06AM	AstraZeneca, Daiichi Sankyo's Datroway receives FDA approval for TNBC (Pharmaceutical Business Review)
May-21-26 05:38AM	Lillys triple-acting obesity drug hits goal in Phase 3 trial (BioPharma Dive)
May-20-26 05:06AM	Big Pharma is gambling on specialized R&D. Will it pay off? (Pharma Voice)

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

M.B.A.Mr. Pascal Claude Roland Soriot D.V.M.

CFO & Executive DirectorDr. Aradhana Sarin M.D.

EVP of Global opt. & ITMs. Pam P. Cheng

Head of Investor RelationsMr. Joris Silon

CHROMr. Jeffrey Pott J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sharma Mani	See Remarks	May 20 '26	Sale	185.78	11,893	2,209,482	19,262	May 22 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AZN

Astrazeneca plc

Upgrade your Finviz experience